Search
Crinetics Pharmaceuticals Inc
CRNXAdd to Watchlist
84.690USD
0.0000.00%
Close 08-21 16:00（ET）
8.96BMarket Cap
LossP/E TTM
Forecast
Currency: USD Updated: 2026-08-21The current earnings forecast score of Crinetics Pharmaceuticals Inc is 6.29, ranking 321 out of 377 in the Biotechnology & Medical Research industry. The average price target is 83.00, with a high of 108.00 and a low of 45.00.
Analyst Rating
Based on
15
analysts
Hold
Current Rating
84.000
Target Price
-0.85%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
497
Total
6
Median
7
Average
Company name
Ratings
Analysts
Crinetics Pharmaceuticals Inc
CRNX
15
argenx SE
ARGX
28
Beigene Ltd
ONC
28
Ionis Pharmaceuticals Inc
IONS
26
IQVIA Holdings Inc
IQV
24
Kymera Therapeutics Inc
KYMR
23
1
2
3
...
100
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Crinetics Pharmaceuticals Inc's expected revenue for the next quarter?
Crinetics Pharmaceuticals Inc's expected revenue is 18.97M.
What is Crinetics Pharmaceuticals Inc's price target?
Analysts forecast that Crinetics Pharmaceuticals Inc's price target is USD 83.00, with the highest forecast at USD 108.00 and the lowest forecast at USD 45.00.
How have Crinetics Pharmaceuticals IncCRNX's recent earnings per share performed?
The market expectation was USD -1.14, while Crinetics Pharmaceuticals IncCRNX's earnings per share (EPS) for the previous quarter was USD -1.23. EPS for the next quarter is expected at USD -1.20.
What is the analyst rating for Crinetics Pharmaceuticals Inc?
Based on the ratings of Crinetics Pharmaceuticals Inc's stock from 15 analysts, most analysts support a signal_hold trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as signal_hold. Please note that this is not trading advice. You still need to conduct your own analysis.